.
MergerLinks Header Logo

New Deal


Announced

Completed

Repligen completed the acquisition of Metenova.

Financials

Edit Data
Transaction Value-
Consideration TypeOrdinary Shares, Cash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

pharmaceutical equipment

Sweden

Medical Equipment

Cross Border

Private

Friendly

Acquisition

Majority

Single Bidder

Completed

Synopsis

Edit

Repligen, a bioprocessing-focused life sciences company, completed the acquisition of Metenova, a manufacturer of magnetic mixers for pharmaceutical and biotechnology use. Financial terms were not disclosed. “The addition of Metenova further strengthens our Fluid Management portfolio, with a product line that expands on the market success of our systems and fluid management assemblies and complements our recently acquired single-use bag business from FlexBiosys. We are excited to welcome the Metenova team to Repligen and we look forward to further developing and integrating their differentiated magnetic mixing technologies into our portfolio," Tony J. Hunt, Repligen President and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US